SVTR 硅谷科技评论SVTR
← Database

IMeditech

IMeditech (Korean: 아이메디텍; registered as IMT Inc.) is a medical device developer and manufacturer headquartered in Gwangju, South Korea, founded in 2023.

Request an introWebsite ↗
ApplicationsLife Sciences
Total funding $1.1BFounded 2023

About

IMeditech (Korean: 아이메디텍; registered as IMT Inc.) is a medical device developer and manufacturer headquartered in Gwangju, South Korea, founded in 2023. Its flagship product Nano-I is a portable electrospinning device producing regenerative, antimicrobial and hemostatic nanofiber wound-care membranes; it also makes and distributes vascular and non-vascular membrane stents, cardiovascular stents, drug-eluting balloon catheters, negative-pressure wound dressings and neurovascular devices. Since 2026 it has been part of a Korea-US government-funded consortium (with Ajou University Hospital, ETRI and a Harvard Medical School researcher) developing a robotic, AI-driven personalized electrospun wound-treatment system for diabetic foot ulcers, severe trauma and burns.

Comparable companies· by market

This company

  • IMeditech

    R&D and manufacturing of electrospun nanofiber wound care devices, vascular stents, catheters and neurointerventional devices…

    $1.1B

Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.

Investors that may fit

Y Combinator

39 Life Sciences deals in the last 24 months

Request intro →

General Catalyst

38 Life Sciences deals in the last 24 months

Request intro →

Andreessen Horowitz

22 Life Sciences deals in the last 24 months

Request intro →

Khosla Ventures

21 Life Sciences deals in the last 24 months

Request intro →

Thrive Capital

18 Life Sciences deals in the last 24 months

Request intro →

Lightspeed

16 Life Sciences deals in the last 24 months

Request intro →

Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.

Want to reach IMeditech — for capital, customers, or partnership? Send a short request; SVTR reviews it and brokers the intro, with both sides verified before you meet.

Request an intro to this companySubscribe to Signal